Recruiting
Phase 2

A Study of Amivantamab in People with Esophagogastric Cancer

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05117931

Conditions

Esophagogastric Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information